These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12433592)

  • 21. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
    Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
    Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels.
    Rocha B; Rigo M; Di Scala G; Sandner G; Hoyer D
    Eur J Pharmacol; 1994 Sep; 262(1-2):125-31. PubMed ID: 7813563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
    Ponzoni A; Monti JM; Jantos H; Altier H; Monti D
    Eur J Pharmacol; 1995 May; 278(2):111-5. PubMed ID: 7671995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep-endocrine profile of the antidepressant mianserin.
    Tormey WP; Buckley MP; O'Kelly DA; Conboy J; Pinder RM; Darragh A
    Curr Med Res Opin; 1980; 6(7):456-60. PubMed ID: 7363645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
    Rajkumar R; Pandey DK; Mahesh R; Radha R
    Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats.
    Tortella FC; Echevarria E; Pastel RH; Cox B; Blackburn TP
    Brain Res; 1989 Apr; 485(2):294-300. PubMed ID: 2720415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic suppression of REM sleep by parenteral administration of the serotonin-1 agonist eltoprazine.
    Quattrochi JJ; Mamelak A; Binder DK; Williams J; Rittenhouse C; Hobson JA
    Sleep; 1992 Apr; 15(2):125-32. PubMed ID: 1579786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls.
    Gillin JC; Sohn JW; Stahl SM; Lardon M; Kelsoe J; Rapaport M; Ruiz C; Golshan S
    Neuropsychopharmacology; 1996 Aug; 15(2):109-15. PubMed ID: 8840346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.
    Moreau JL; Jenck F; Martin JR; Perrin S; Haefely WE
    Psychopharmacology (Berl); 1993; 110(1-2):140-4. PubMed ID: 7870874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-related suppression of REM sleep and PGO waves by the serotonin-1 agonist eltoprazine.
    Quattrochi JJ; Mamelak AN; Binder D; Williams J; Hobson JA
    Neuropsychopharmacology; 1993 Jan; 8(1):7-13. PubMed ID: 8424848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apamin, a selective SK potassium channel blocker, suppresses REM sleep without a compensatory rebound.
    Benington JH; Woudenberg MC; Heller HC
    Brain Res; 1995 Sep; 692(1-2):86-92. PubMed ID: 8548324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of spinal 5-HT receptors in cutaneous hypersensitivity induced by REM sleep deprivation.
    Wei H; Ma A; Wang YX; Pertovaara A
    Pharmacol Res; 2008 Jun; 57(6):469-75. PubMed ID: 18602835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in sleep EEG architecture during the treatment of depressed patients with mianserin.
    Mendlewicz J; Dunbar GC; Hoffman G
    Acta Psychiatr Scand Suppl; 1985; 320():26-9. PubMed ID: 3863466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.